SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Silence Therapeutics Highlights Recent Business Achievements and Reports Third Quarter 2026 Financial Results

LONDON--(BUSINESS WIRE)-- Silence Therapeutics plc, (Nasdaq: SLN), a global clinical-stage company d

SLN

Related stories